VolitionRX Ltd (VNRX)

Sep 30, 2026

Neither party sold shares as VolitionRx (VNRX) retained 284 shares for its commercial chief’s taxes. - Stock Titan

Sep 30, 2026

Sep 30, 2026

No shares were sold as VolitionRx (VNRX) retained 608 COO shares for cancellation to cover taxes. - Stock Titan

Sep 30, 2026

Sep 22, 2026

Lagoda Investment Management, L.P. Trims VolitionRX Ltd (VNRX) S - GuruFocus

Sep 22, 2026

Sep 17, 2026

VolitionRx joins France sepsis detection consortium By Investing.com - Investing.com South Africa

Sep 17, 2026

Sep 17, 2026

VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France - Barchart.com

Sep 17, 2026

Sep 17, 2026

A €6.3 million French program will test one blood marker to spot sepsis early - Stock Titan

Sep 17, 2026

Sep 16, 2026

One manager now reports nearly 6% of VolitionRx (NYSE: VNRX) - Stock Titan

Sep 16, 2026

Sep 15, 2026

VolitionRx issues shares for note conversions, updates outstanding share count By Investing.com - Investing.com South Africa

Sep 15, 2026

Sep 15, 2026

Form 8K Volitionrx Ltd For: 15 September By Investing.com - Investing.com India

Sep 15, 2026

Sep 15, 2026

VolitionRx (AMEX: VNRX) Settles $7.5M Convertible Note Early, Mitigates Equity Dilution Risk - kalkinemedia.com

Sep 15, 2026

Sep 14, 2026

Form 8K Volitionrx Ltd For: 14 September By Investing.com - Investing.com Nigeria

Sep 14, 2026

Sep 11, 2026

Volitionrx Ltd (NYSE: VNRX) Share Price, VNRX Stock News, VNRX Share Price & Updates - Kalkine

Sep 11, 2026

Sep 11, 2026

VOLITIONRX LTD SEC Filing (Sep 11, 2026) - Stock Titan

Sep 11, 2026

Sep 10, 2026

Lagoda Investment Management, L.P. Adds VolitionRX Ltd (VNRX) -- Shares Look 98% Undervalued on GF Value - GuruFocus

Sep 10, 2026

Sep 10, 2026

VNRX Looks 98.1% Undervalued on GF Value™ Despite Financial Dist - GuruFocus

Sep 10, 2026

Sep 10, 2026

A blood-based method detected 95% of stage I and II cancers. - Stock Titan

Sep 10, 2026

Sep 09, 2026

Dilution risk flagged as VolitionRx (NYSE: VNRX) registers more Lind shares for resale - Stock Titan

Sep 09, 2026

Sep 08, 2026

VolitionRx (NYSE: VNRX) details Lind note and warrant stake under 4.99% cap - Stock Titan

Sep 08, 2026

Sep 08, 2026

Lagoda Investment Management Elevates VOLITIONRX LTD (AMEX: VNRX) Stake to Activist 13D Filing at 7.4% - Kalkine Media

Sep 08, 2026

Sep 08, 2026

VNRX - Finviz

Sep 08, 2026

Sep 04, 2026

Fatima Dickey Pushes for Changes at VolitionRx with 7.4% Stake - tradingview.com

Sep 04, 2026

Sep 04, 2026

$11M VolitionRx (VNRX) stake comes with call to cut executive pay - Stock Titan

Sep 04, 2026

Sep 02, 2026

VolitionRx Removes $10M Annual Cap on ATM Sales Via Lind Waiver - Minichart

Sep 02, 2026

Aug 31, 2026

$VolitionRX (VNRX.US)$ it be like that. not even tripping cuz! - Moomoo

Aug 31, 2026

Aug 28, 2026

VolitionRx Files for Secondary Offering of Common Shares - Moomoo

Aug 28, 2026

Aug 28, 2026

This $21 Stock Has CRAZY Potential Baby Sleep (NynJ4YJi1C) - mshale.com

Aug 28, 2026

Aug 28, 2026

Nasdaq Surges 200 Points; Nvidia Posts Upbeat Q2 Results - Sahm

Aug 28, 2026

Aug 27, 2026

VolitionRx lateral flow test correlates with legacy assay in sepsis patients - scanx.trade

Aug 27, 2026

Aug 27, 2026

Penny Stock VolitionRx Expands Addressable Markets With Key Diagnostic Validations - Benzinga

Aug 27, 2026

Aug 27, 2026

$VolitionRX (VNRX.US)$ - Moomoo

Aug 27, 2026

Aug 26, 2026

VolitionRx revenue rises 112% in H1FY26; shares surge 100% - scanx.trade

Aug 26, 2026

Aug 26, 2026

VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets - Yahoo Finance

Aug 26, 2026

Aug 17, 2026

VolitionRX Ltd (VNRX) (Q2 2026) Earnings Call Highlights: Strate - GuruFocus

Aug 17, 2026

Aug 17, 2026

Benchmark reiterates Hold on VolitionRX stock amid cost cuts - Investing.com

Aug 17, 2026

Aug 17, 2026

Benchmark reiterates Hold on VolitionRX stock amid cost cuts By Investing.com - Investing.com Canada

Aug 17, 2026

Aug 17, 2026

VNRX Looks 97.6% Undervalued on GF Value™ - GuruFocus

Aug 17, 2026

Aug 14, 2026

Lagoda Investment discloses 14.0% VolitionRX (VNRX) stake in amended Schedule 13G - Stock Titan

Aug 14, 2026

Aug 14, 2026

Teleconferência de Resultados do 2º Trimestre de 2026 da VolitionRx (VNRX): Custos Caem à Medida que o Pipeline Nu.Q Avança - TradingKey

Aug 14, 2026

Aug 14, 2026

Conferencia de resultados del Q2 de 2026 de VolitionRx (VNRX): los costos caen a medida que avanza la cartera de desarrollo de Nu.Q - TradingKey

Aug 14, 2026

Aug 14, 2026

VolitionRx (VNRX) Q2 2026 Ergebniskonferenz: Kosten sinken bei Fortschritten der Nu.Q-Pipeline - TradingKey

Aug 14, 2026

Aug 14, 2026

Volitionrx Ltd earnings beat by $0.06, revenue fell short of estimates - Investing.com Canada

Aug 14, 2026

Aug 14, 2026

Transcript : VolitionRx Limited, Q2 2026 Earnings Call, Aug 14, 2026 - marketscreener.com

Aug 14, 2026

Aug 14, 2026

Earnings call transcript: VolitionRX misses Q2 2026 estimates as shares slip - Investing.com Canada

Aug 14, 2026

Aug 14, 2026

VolitionRX Reports Q2 2026 Results: Full Earnings Call Transcript - Benzinga

Aug 14, 2026

Aug 14, 2026

VolitionRx Limited Q2 2026 Earnings Call Summary - Yahoo Finance

Aug 14, 2026

Aug 14, 2026

VolitionRx Q2 Revenue Flat, but Licensing Talks and $5M Milestone Ahead - Minichart

Aug 14, 2026

Aug 14, 2026

Form 8K Volitionrx Ltd For: 13 August - Investing.com India

Aug 14, 2026

Aug 13, 2026

VolitionRx targets $3.8B sepsis market with Nu.Q NETs platform - scanx.trade

Aug 13, 2026

Aug 13, 2026

VolitionRX: Q2 Earnings Snapshot - marketscreener.com

Aug 13, 2026

Aug 13, 2026

VolitionRx Q2 2026: Operating expenses fall 32% to $4.6 million - scanx.trade

Aug 13, 2026

Aug 13, 2026

Form 8K Volitionrx Ltd For: 13 August By Investing.com - Investing.com Nigeria

Aug 13, 2026

Aug 13, 2026

VolitionRx (VNRX) flags going concern risk amid $14M loss and NYSE plan - Stock Titan

Aug 13, 2026